Back to all bills
HR 2197119th CongressIntroduced
No 340B Savings for Transgender Care Act
Introduced: Oct 18, 2025
Standard Summary
Comprehensive overview in 1-2 paragraphs
The No 340B Savings for Transgender Care Act prohibits 340B covered entities from using savings from discounted drugs to pay for sex reassignment surgeries and hormone treatments for gender transition.
Key Points
- 1Prohibits use of 340B drug savings for gender transition services
- 2Covers sex reassignment surgeries and hormone treatments
- 3Applies to all 340B program participating covered entities
- 4Defines 'services described' as gender transition procedures
- 5Amends Public Health Service Act Section 340B(a)(4)
- 6Restricts how 340B savings can be allocated
Impact Areas
340B drug pricing programTransgender healthcare accessHospital and clinic fundingPharmaceutical pricing policyGender-affirming care services
Generated by kwaipilot/kat-coder-pro:free on Nov 21, 2025